Physicians and patients seek cancer susceptibility genetic testing to mitigate potential risks and seek early interventions. Clinical molecular laboratories looking to expand their assays to meet these needs must take into account the requirements related to technical aspects of testing, patient populations, genetic counseling support, and reimbursement.
Download this guide from Velsera to learn how laboratories navigate hereditary cancer testing in the context of clinically relevant scenarios.